The genetics of mental retardation

Current Opinion in Psychiatry

Volumn 11, Issue 5, 1998, Pages 507-513

  Tolmie, John ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN MALFORMATION; CHROMOSOME ABERRATION; FRAGILE X SYNDROME; GENETICS; HUMAN; IDIOPATHIC DISEASE; MENTAL DEFICIENCY; PATHOGENESIS; REVIEW;

EID: 0031659173     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-199809000-00014     Document Type: Review

References (66)

1. Siminoff E, Bolton P, Rutter M. Mental retardation: genetic findings, clinical implications and research agenda. J Child Psychiatry 1996; 37:259-280.
2. Raynham H, Gibbons R, Flint J, Higgs D. The genetic basis for mental retardation. Q J Med 1996; 89:169-175.
3. Roeleveld N, Zielhuis GA. The prevalence of mental retardation: a critical review of recent literature. Dev Med Child Neurol 1997; 39:125-132. This is just what the title says!
4. Stromme P, Varvatne K. Mental retardation in Norway: prevalence and sub-classification in a cohort of 30037 children born between 1980 and 1985. Acta Paediatr 1998; 87:291-296. It is important to keep up to date with such studies - they provide essential raw data for health-care providers, educationalists, epidemiologists, etc. However, one should always take particular note of the genetic composition of the population under scrutiny.
5. Curry CJ, Stevenson RE, Aughton D, Byrne J, Carey JC, Cassidy S, et al. Evaluation of mental retardation: recommendations of a consensus conference: American College of Medical Genetics. Am J Med Genet 1997; 72:468-477. This is essential reading for all clinicians in the field, and presents a good common-sense approach to the problem.
6. Majnemer A, Shevell MI. Diagnostic yield of the neurologic assessment of the developmentally delayed child. J Pediatr 1995; 127:193-199.
7. Deb S. Structural neuroimaging in learning disability. Br J Psychiatry 1997; 171:417-419.
8. Yeargin-Allsopp M, Murphy C, Cordero JF, Decoufle P, Hollowell JG. Reported biomedical causes and associated conditions for mental retardation among 10-year-old children, metropolitan Atlanta, 1985-1987. Dev Med Child Neurol 1997; 39:142-149. The authors found administrative prevalence for mental retardation in 10-year-old children was 12/1000 (8.4/1000 had IQ in range 50-70; 3.6/1000 had IQ <50). There is an excellent account of problems in deciding what constitutes aetiology and reasons for variation in the proportion of cases with identifiable aetiology.
9. Minns RA. Pre- and perinatal conditions contributing to mental retardation. Curr Opin Psychiatry 1997; 10:354-359.
10. Crow YJ, Tolmie JL. Recurrence risks in mental retardation. J Med Genet 1998; 35:177-182. This paper makes depressing reading for those who think that either literature or geneticists are a source of sound, consistent advice for families on risk of recurrence of mental retardation.
11. Ledbetter DH. Minireview. Cryptic translocations and telomere integrity. Am J Hum Genet 1992; 5:451-456
12. Flint J, Wilkie AOM, Buckle VJ, Winter RM, Holland AJ, McDermid HE. The detection of subtelomeric chromosomal rearrangements in idiopathic mental retardation. Nature Genet 1995; 9:132-140
13. Knight JL, Horsley SW, Regan R, Lawrie MN, Cardy D, Maher E, et al. Development and clinical application of an innovative fluorescence in situ hybridization technique which detects submicroscopic rearrangements involving the telomeres. Eur J Hum Genet 1997; 13:1-8. This important paper contains technical detail of laboratory, diagnostic FISH testing.
14. Frangiskakis JM, Ewart A, Morris CA, Mervis B, Bertrand J, Robinson BF,et al. LIM-kinase 1 hemizygosity implicated in impaired visuospatial constructive cognition. Cell 1996; 86:59-69.
15. Wong ACC, Ning Y, Flint J, Clark K, Dumanski JP, Ledbetter DH, McDermid HE. Molecular characterization of a 130-kb terminal microdeletion at 22q in a child with mild mental retardation. Am J Hum Genet 1997; 60:113-112.
16. Flint J. Behavioural phenotypes: conceptual and methodological issues. Am J Med Genet 1998; 81:235-240. This paper is absolutely essential reading for everyone, as is everthing else Flint writes on this topic!
17. National Institutes of Health and Institute of Molecular Medicine Collaboration. A complete set of human telomeric probes and their clinical application [letter]. Nature Genet 1996; 14:86-87.
18. Ghaffari SR, Boyd E, Tolmie JL, Crow YJ, Trainer AH, Connor JM. A new strategy for cryptic telomeric translocation screening in patients with idiopathic mental retardation. J Med Genet 1998; 35:225-233. This technical paper shows the potential power of this technique once it has been adapted for use in genetic diagnosis.
19. Budarf ML, Emanuel BS. Progress in the segmental aneusomy syndromes (SASs): single or multi-locus disorders?. Hum Molec Genet 1997; 6:1657-1665. Handy, very detailed, very strong on genetics, this is an excellent review of microdeletion syndromes.
20. Carlson C, Papolos D, Pandita RK, Faedda GL, Veit S, Goldberg R, et al. Molecular analysis of velo-cardio-facial syndrome patients with psychiatric disorders. Am J Hum Genet 1997; 60:851-859.
21. Crino PB, Eberwine J. Cellular and molecular basis of cerebral dysgenesis. J Neurosci Res 1997; 50:907-916.
22. Online Mendelian Inheritance in Man, OMIM (TM). Center for Medical Genetics, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD), 1997. World Wide Web URL: http://www.ncbi.nlm.nih.gov/omim/. This has been called the geneticist's bible but to paraphrase the late Bill Shankly, actually, it's much more important than that!
23. Glen CC, Driscoll DJ, Yang TP, Nicholls RD. Genomic imprinting: potential function and mechanisms revealed by the Prader-Willi and Angelman syndrome. Molec Hum Reprod 1997; 3:321-332. A detailed and comprehensive review of a complex genetic process is presented.
24. Tilghman SM, Caspary T, Ingram RS. Competitive edge at the imprinted Prader-Willi/Angelman syndrome region? Nature Genet 1998; 18:206-208.
25. Kishino T, Lalande M, Wagstaff J. UBE3A/E6AP mutations cause Angelman syndrome. Nature Genet 1997; 15:70-73.
26. Matsuura T, Sutcliffe JS, Fang P, Galjaard R-J, Jiang Y, Benton CS, et al. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nature Genet 1997; 15:74-77.
27. •,28-30] also aid understanding.
28. Gilbert HL, Button JL, Chan CTJ, McKay T, Cottrell S, Ramsden S, et al. Counselling dilemmas associated with the molecular characterisation of two Angelman syndrome families. J Med Genet 1997; 34:651-655.
29. Stalker HJ, Williams CA. Genetic counselling in Angelman syndrome: the challenges of multiple causes. Am J Med Genet 1998; 77:54-59.
30. Burger J, Buiting K, Dittrich B, Grob S, Lich C, Sperling K, et al. Different mechanisms and recurrence risks of imprinting defects in Angelman syndrome. Am J Hum Genet 1997; 61:88-93.
31. Chakrabarti L, Davies KE. Fragile X syndrome. Curr Opin Neurol 1997; 10:142-147. An excellent review from the experts on fragile X molecular genetics is presented.
32. Turner G, Webb D, Wake S, Robinson H. Prevalence of the fragile X syndrome. Am J Med Genet 1996; 64:196-197.
33. Chakrabarti L, Knight SJL, Flannery AV, Davies KE. A candidate gene for mild mental retardation at the FRAXE fragile site. Hum Mol Genet 1996; 5:275-282.
34. Barnicoat AJ, Wang Q, Turk J, Green E, Matthew CG, Flynn G, et al. Clinical, cytogenetic and molecular analysis of three families with FRAXE. J Med Genet 1997; 34:13-17. The FRAXE phenotype is rare and far from established; this paper and [35] are therefore essential reading for everyone with an interest in medical genetic causes of milder learning difficulties.
35. •].
36. •,35].
37. Weiler IJ, Irwin SA, Klintsova AY, Spencer CM, Brazelton AD, Miyashiro K, et al. Fragile X protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci Usa 1997; 94:5395-5400.
38. Tamini F, Willemsen R, van Unen L, Bontekoe C, Galjaard H, Oostra BA, Hoogeveen AT. Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testes. Hum Molec Genet 1997; 6:1315-1322.
39. •,41-48] give, in total, a clear picture of why it is difficult to find fragile X syndrome cases (the syndrome is not as common as once was thought) and, once found, how the genetic implications may be raised with the families.
40. Turner G, Robinson H, Wake S, Laing S, Partington M. Case finding for the fragile X syndrome and its consequences. Br Med J 1997;315:1223-1226. This is an excellent account of clinical genetics in practice.
41. Barnicoat A. Screening for fragile X syndrome: a model for genetic disorders? [editorial]. Br Med J 1997; 315:1174-1175.
42. Mazzocco MM, Sonna NL, Teisl JT, Pinit A, Shapiro BK, Shah N, Reiss AL. The FMR1 and FMR2 mutations are not common etiologies of academic difficulty among school age children. J Dev Behav Pediatr 1997; 18:392-398.
43. Corrigan N, Stewart M, Scott M, Fee F. Fragile X, iron and neurodevelopmental screening in 8 year old children with mild to moderate learning difficulties. Arch Dis Child 1997; 76:264-267.
44. O'Dwyer J, Holmes J, Mueller R, Taylor G. The prevalence of fragile-X syndrome in an institution for people weith learning disability. Psychiatr Genet 1997; 7:115-119.
45. Mila M, Sanchez A, Badenas C, Brun C, Jimenez D, Villa MP, et al. Screening for FMR1 and FMR2 mutations in 222 individuals from Spanish special schools: identification of a case of FRAXE-associated mental retardation. Hum Genet 1997; 100:503-507.
46. Gurling HM, Bolton PF, Vincent J, Melmer G, Rutter M. Molecular and cytogenetic investigations of the fragile X region including the Frax A and Frax E CGG trinucleotide repeat sequences in families multiplex for autism and related disorders. Hum Hered 1997; 47:254-262.
47. Kluck SM, Munstermann E, Bieber-Martig B, Ruhl D, Lisch S, Schmotzer G, et al. Molecular genetic analysis of the FMR-1 gene in a large collection of autistic patients. Hum Genet 1997; 100:224-229.
48. Gringras P, Barnicoat A. Retesting for fragile X syndrome in cytogenetically normal males. Dev Med Child Neurol 1998; 40:62-64.
49. Turner G. Invited editorial. Finding genes on the X chromosome by which homo may have become sapiens. Am J Hum Genet 1996; 58:1109-1110.
50. Lubs HA, Chiurazzi P, Fernando Arena J, Schwartz C, Tranebjaerg L, Neri G. XLMR genes: update 1996. Am J Med Genet 1996; 64:147-157.
51. Gideon AK, Donnelly AJ, Mulley JC, Kerr B, Turner G. How many genes for non-specific mental retardation (MRX) are there? Am J Med Genet 1996; 64:158-162.
52. Stevenson RE, Arena JF, Ouzts E, Gibson A, Shokeir MHK, Vnencak-Jones C, et al. Renpenning syndrome maps to Xp11. Am J Hum Genet 1998; 62:1092-1101. This is an excellent clinical and molecular genetic study on the family with XLMR who were first reported by Renpenning when he was a medical student in 1962. This condition's place among other XLMR syndromes is also discussed most informatively with a historical slant.
53. Crow YJ, Zuberi SM, McWilliam R, Tolmie JL, Hollman A, Pohl K, Stephenson JBP. 'Cataplexy' in Coffin-Lowry syndrome. J Med Genet 1998; 35:94-98. This is a fascinating syndrome and the paper illustrates the importance of detailed clinical neurological assessment in patients with mental retardation who have 'funny turns'.
54. Ryan SG, Chance PF, Zou C-H, Spinner NB, Golden JA, Smietana S. Epilepsy and mental retardation limited to females: an X-linked dominant disorder with male sparing. Nature Genet 1997; 17:92-95. This is a unique disorder, and even nongeneticists could be fascinated by the inheritance pattern illustrated on the family tree diagram.
55. Naidu S. Rett syndrome: a disorder affecting early brain growth. Ann Neurol 1997; 42:3-10. A comprehensive review is presented.
56. Schanen NC, Dahle EJR, Capozzoli F, Holm VA, Zoghbi HY, Francke U. A new Rett syndrome family consistent with X-linked inheritance expands the X chromosome exclusion map. Am J Hum Genet 1997; 61:634-641. What if Rett syndrome is due to something(s) other than an X-chromosome linked gene defect that is lethal in males? Taken as a whole, the clinical and molecular genetic evidence is not overwhelming.
57. Bolton P, Macdonald H, Pickles A, Rios P, Goode S, Crowson M, et al. A case-control family history study of autism. J Child Psychol Psychiatry 1994; 35:877-890.
58. Fombonne E, Bolton P, Prior J, Jordan H, Rutter M. A family study of autism: cognitive patterns and levels in parents and siblings. J Child Psychol Psychiatry 1997; 38:667-683. This paper is essential reading for all psychiatrists and geneticists with an interest in autism.
59. Rapin I, Katzman R. Neurobiology of autism. Ann Neurol 1998; 43:7-14. A good, concise review is presented.
60. Rutter M, Bailey A, Bolton P, Le Couteur A. Autism and known medical conditions: myth and substance. J Child Psychol Psychiatry 1994; 35:311-322.
61. Cook EH, Courchesne RY, Cox NJ, Lord C, Gonen D, Guter SJ, et al. Linkage-disequilibrium mapping of autistic disorder with 15q11-13 markers. Am J Hum Genet 1998; 62:1077-1083.
62. International Molecular Genetic Study of Autism Consortium. A full genome screen for autism with evidence for linkage to a region on chromosome 7q. Hum Molec Genet 1998; 7:571-578. This is an important research paper: a collaborative study using latest genetic technologies.
63. Hurst JA, Baraitser M, Auger E, Graham F, Norell S. An extended family with a dominantiy inherited speech disorder. Dev Med Child Neurol 1990; 32:347-355.
64. Fisher SE, Vargha-Khadem F, Watkins KE, Monaco AP, Pembrey ME. Localisation of a gene implicated in a severe speech and language disorder. Nature Genet 1998; 18:168-170. This is a genetic paper, but it also has a good summary that refers to previous neuroscience studies on this, probably the most intensively investigated, speech impaired family anywhere in the world.
65. •] are essential reading for all who have an interest in the genetic basis of cognitive disorders.
66. ••].